Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 24 | Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | |
|---|---|---|---|---|---|
| Sales | 74.03 | 74.69 | 61.44 | 43.49 | 47.23 |
| Operating profit | 15.83 | 16.29 | 10.24 | 2.67 | 3.40 |
| Interest | 0.26 | 0.23 | 0.22 | 0.22 | 0.23 |
| Gross profit | 17.90 | 17.71 | 11.47 | 4.94 | 5.69 |
| EPS (Rs) | 4.82 | 1.73 | 0.81 | 0.54 | 0.60 |
Quarterly
results in details
| Dec' 24 | Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | |
|---|---|---|---|---|---|
| Other income | 2.32 | 1.65 | 1.44 | 2.49 | 2.52 |
| Stock adjustment | 0.13 | -0.87 | -2.12 | 1.81 | -0.29 |
| Raw material | 5.27 | 5.20 | 4.39 | 3.79 | 5.88 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 16.82 | 16.68 | 14.74 | 11.45 | 11.64 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 35.98 | 37.40 | 34.19 | 23.77 | 26.61 |
| Provisions made | - | - | - | - | - |
| Depreciation | 2.41 | 2.34 | 1.07 | 0.40 | 0.41 |
| Taxation | 6.68 | 3.91 | 1.78 | 0.99 | 1.32 |
| Net profit / loss | 31.99 | 11.46 | 5.33 | 3.55 | 3.96 |
| Extra ordinary item | 23.18 | - | -3.29 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 13.27 | 13.24 | 13.23 | 13.22 | 13.14 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 21.39 | 21.80 | 16.66 | 6.14 | 7.19 |
| GPM (%) | 23.45 | 23.20 | 18.24 | 10.74 | 11.44 |
| NPM (%) | 41.90 | 15.01 | 8.47 | 7.72 | 7.97 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis